BioAtla Inc (NASDAQ: BCAB) is -36.86% lower on its value in year-to-date trading and has touched a low of $0.24 and a high of $4.02 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The BCAB stock was last observed hovering at around $0.39 in the last trading session, with the day’s loss setting it -0.02%.
Currently trading at $0.37, the stock is 7.77% and -7.81% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.44 million and changing -4.92% at the moment leaves the stock -71.27% off its SMA200. BCAB registered -87.60% loss for a year compared to 6-month loss of -76.89%. The firm has a 50-day simple moving average (SMA 50) of $0.405 and a 200-day simple moving average (SMA200) of $1.299245.
The stock witnessed a 19.15% gain in the last 1 month and extending the period to 3 months gives it a -39.85%, and is 6.29% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 13.96% over the week and 12.67% over the month.
BioAtla Inc (BCAB) has around 76 employees, a market worth around $21.66M and $11.00M in sales. Profit margin for the company is -634.33%. Distance from 52-week low is 55.54% and -90.71% from its 52-week high. The company has generated returns on investments over the last 12 months (-489.14%).
The EPS is expected to grow by 23.67% this year, but quarterly earnings will post -93.64% year-over-year. Quarterly sales are estimated to shrink 0.00% in year-over-year returns.
BioAtla Inc (BCAB) Top Institutional Holders
83.0 institutions hold shares in BioAtla Inc (BCAB), with institutional investors hold 57.93% of the company’s shares. The shares outstanding are 58.10M, and float is at 45.08M with Short Float at 9.37%. Institutions hold 52.33% of the Float.
The top institutional shareholder in the company is SOLEUS CAPITAL MANAGEMENT, L.P. with over 3.9 million shares valued at $5.34 million. The investor’s holdings represent 8.0915% of the BCAB Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 1.89 million shares valued at $2.58 million to account for 3.9205 of the shares outstanding. The other top investors are MORGAN STANLEY which holds 1.85 million shares representing 3.8469% and valued at over $2.54 million, while MILLENNIUM MANAGEMENT LLC holds 3.4206 of the shares totaling 1.65 million with a market value of $2.26 million.
BioAtla Inc (BCAB) Insider Activity
#####
